Guangzhou Sonostar Technologies Co., Limited
Sonostar Technologies Co., Limited is specialized in R&D, production and sales. We provide state-of-the-art medical equipment ranging from ultrasound equipment to patient monitoring, ophthalmic, dental and respirator equipment.
We insist on making modern medical technology affordable without compromising quality.
We have extensive experience offering ODM and OEM services for many domestic and overseas enterprises, and we began entering international markets in recent years.
Our motto and aim is "New Tech, New Life". And we mean it. As a company, we strive to popularize and utilize advanced technology, thus benefitting patients, their families and medical professionals alike.
Our friendly costumer service is ready to help in the case of any questions or concerns.
We warmly welcome potential business partners and the medical community to join hands with us in our endeavour to make the world a better place.
Our main products:Ultrasound Scanner,Probe Type Ultrasound Scanner,B/W Ultrasound Scanner ,Vet Ultrasound Scanner, Ophthalmology Scanner ect.
Guangzhou Sonostar Technologies Co., Limited
Sonostar Technologies Co., Limited is specialized in R&D, production and sales. We provide state-of-the-art medical equipment ranging from ultrasound equipment to patient monitoring, ophthalmic, dental and respirator equipment.
We insist on making modern medical technology affordable without compromising quality.
We have extensive experience offering ODM and OEM services for many domestic and overseas enterprises, and we began entering international markets in recent years.
Our motto and aim is "New Tech, New Life". And we mean it. As a company, we strive to popularize and utilize advanced technology, thus benefitting patients, their families and medical professionals alike.
Our friendly costumer service is ready to help in the case of any questions or concerns.
We warmly welcome potential business partners and the medical community to join hands with us in our endeavour to make the world a better place.
Our main products:Ultrasound Scanner,Probe Type Ultrasound Scanner,B/W Ultrasound Scanner ,Vet Ultrasound Scanner, Ophthalmology Scanner ect.
Hologic is a global medical technology company focused on improving women's health through early detection and treatment.
Hologic, Inc.
Hologic is a global medical technology company focused on improving women's health through early detection and treatment.
Varian Medical Systems, Inc.
A global leader in medical devices and software for cancer treatment, providing advanced radiation therapy and imaging solutions.
Varian Medical Systems, Inc.
A global leader in medical devices and software for cancer treatment, providing advanced radiation therapy and imaging solutions.
A global leader in dental solutions, offering innovative implant systems, digital technologies, and restorative materials.
Dentsply Sirona Inc.
A global leader in dental solutions, offering innovative implant systems, digital technologies, and restorative materials.
Beckman Coulter, a Danaher company, offers innovative solutions for biomedical testing, including microplate readers, flow cytometers, and automation systems.
Beckman Coulter, Inc.
Beckman Coulter, a Danaher company, offers innovative solutions for biomedical testing, including microplate readers, flow cytometers, and automation systems.
Esaote specializes in ultrasound and MRI systems, with a focus on innovative diagnostic imaging solutions for various medical applications.
Esaote S.p.A.
Esaote specializes in ultrasound and MRI systems, with a focus on innovative diagnostic imaging solutions for various medical applications.
Ziehm Imaging specializes in mobile C-arms and imaging systems for surgery and interventional procedures, known for their reliability and advanced features.
Ziehm Imaging GmbH
Ziehm Imaging specializes in mobile C-arms and imaging systems for surgery and interventional procedures, known for their reliability and advanced features.
Toshiba Medical Systems offers a range of imaging solutions, including CT, MRI, and ultrasound systems, with a focus on innovation and clinical excellence.
Toshiba Corporation
Toshiba Medical Systems offers a range of imaging solutions, including CT, MRI, and ultrasound systems, with a focus on innovation and clinical excellence.
GE Vingmed specializes in cardiology imaging systems and solutions, providing advanced diagnostic tools for cardiovascular care.
GE Healthcare
GE Vingmed specializes in cardiology imaging systems and solutions, providing advanced diagnostic tools for cardiovascular care.
Becton, Dickinson and Company
BD is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents.
Becton, Dickinson and Company
BD is a global medical technology company that develops, manufactures, and sells medical devices, instrument systems, and reagents.
Agilent Technologies, Inc.
Agilent Technologies specializes in life sciences, diagnostics, and applied chemical markets, providing analytical instruments and software for research and development.
Agilent Technologies, Inc.
Agilent Technologies specializes in life sciences, diagnostics, and applied chemical markets, providing analytical instruments and software for research and development.
Carl Zeiss is a German company specializing in optics and precision engineering, producing precision plates and components for various applications.
Carl Zeiss AG
Carl Zeiss is a German company specializing in optics and precision engineering, producing precision plates and components for various applications.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Medtronic (Shanghai) Management Co., Ltd.
Because of extraordinary technology, life is facing severe health challenges, Medtronic uses advanced medical technology to bring extraordinary life experience to patients and inspire hope and possibilities in people's lives. Every day, many people face severe health challenges, but ordinary life is a luxury for them. When a type I diabetic patient went out to a friend's house, his father often worried about his son's blood sugar soaring; a woman with an arrhythmia was worried all day long. Some things that seem natural to ordinary people are troubled and struggled by. As a global medical technology company, Medtronic has expectations and strives to achieve more possibilities through innovation and its own profession, bringing patients an extraordinary life experience. Medtronic is committed to solving the complex challenges facing today's healthcare systems, and its business has expanded to more than 70 key disease areas. Medtronic acts quickly and seizes the day to serve more patients around the world with medical technology. Introduce data, artificial intelligence, automation technologies based on patient needs – turning insights into actions to make continuous improvements to the healthcare system. We hope to use technology to ignite the hope of life for patients and bring new possibilities. Medtronic operates in more than 150 countries and regions and has more than 90,000 employees worldwide. We expand access and strive to create more positive impacts beyond our own products. We are committed to promoting inclusion, diversity and equity, and we are committed to protecting our planet to create better results for all.
Abbott Trading (Shanghai) Co., Ltd.
In 1888, Abbott Pharmaceutical Factory was founded in Chicago, USA by its founder, Dr. Wallace C. Abbott, to help people in more than 160 countries and regions around the world live a wonderful life. Abbott has been operating in China as early as the 1930s and has been operating since 1988. Abbott is rooted in China and continues to expand its market. In the past 30 years, it has provided Chinese consumers with a variety of nutritional products, medicines and medical products. At present, in addition to establishing a Chinese headquarters in Shanghai, Abbott has also established 16 offices, 4 factories and 2 R&D centers, with more than 6,000 employees. Abbott develops, produces and distributes products covering nutritional products, medicines, medical devices and diagnostic products. Products and services meet the needs of many aspects from disease prevention to diagnosis, treatment to recovery, and are based on local needs to achieve common health goals. Since 2010, Abbott has continued to invest in the Chinese market, developing, producing and distributing products in China, covering nutritional products, medicines, medical devices and diagnostic products, products and services that can meet the needs of disease prevention to diagnosis and treatment to recovery. . In 2014, the advanced nutritional products factory established in Jiaxing with an investment of US$230 million was officially opened. This is a major investment project in China, showing Abbott's strong attempt to improve the health of all Chinese people. Abbott attaches importance to China's local R&D capabilities, not only establishes R&D centers in Shanghai, but also establishes Shanghai Children's Medical Center with partners. Through local clinical trials and operations, Abbott China's R&D capabilities have been greatly improved. In terms of medical innovation, Abbott China has worked together with other R&D centers around the world to jointly respond to global medical problems. Abbott believes in the potential of life and continues to launch high-quality products and services, ranging from newborns to adults, from nutrition and diagnostics to health care and medical treatment. Abbott's passion and care make science an inexhaustible spring for a healthy life, committed to stimulating everyone's potential and pursuing a healthier and better life.
Abbott Trading (Shanghai) Co., Ltd.
In 1888, Abbott Pharmaceutical Factory was founded in Chicago, USA by its founder, Dr. Wallace C. Abbott, to help people in more than 160 countries and regions around the world live a wonderful life. Abbott has been operating in China as early as the 1930s and has been operating since 1988. Abbott is rooted in China and continues to expand its market. In the past 30 years, it has provided Chinese consumers with a variety of nutritional products, medicines and medical products. At present, in addition to establishing a Chinese headquarters in Shanghai, Abbott has also established 16 offices, 4 factories and 2 R&D centers, with more than 6,000 employees. Abbott develops, produces and distributes products covering nutritional products, medicines, medical devices and diagnostic products. Products and services meet the needs of many aspects from disease prevention to diagnosis, treatment to recovery, and are based on local needs to achieve common health goals. Since 2010, Abbott has continued to invest in the Chinese market, developing, producing and distributing products in China, covering nutritional products, medicines, medical devices and diagnostic products, products and services that can meet the needs of disease prevention to diagnosis and treatment to recovery. . In 2014, the advanced nutritional products factory established in Jiaxing with an investment of US$230 million was officially opened. This is a major investment project in China, showing Abbott's strong attempt to improve the health of all Chinese people. Abbott attaches importance to China's local R&D capabilities, not only establishes R&D centers in Shanghai, but also establishes Shanghai Children's Medical Center with partners. Through local clinical trials and operations, Abbott China's R&D capabilities have been greatly improved. In terms of medical innovation, Abbott China has worked together with other R&D centers around the world to jointly respond to global medical problems. Abbott believes in the potential of life and continues to launch high-quality products and services, ranging from newborns to adults, from nutrition and diagnostics to health care and medical treatment. Abbott's passion and care make science an inexhaustible spring for a healthy life, committed to stimulating everyone's potential and pursuing a healthier and better life.
Siemens Medical is a world-renowned medical technology company. For 130 years, it has led the innovation of medical technology. The company continues to develop innovative products and services, including artificial intelligence-based applications and digital products that play an increasingly important role in the development of the new generation of medical technology, and further consolidates the fields of in vitro diagnosis, image-guided treatment, in vivo diagnosis and new cancer diagnosis and treatment. The basis of At the same time, Siemens Medical provides a wide range of services and solutions to help medical service providers improve their capabilities and provide patients with high-quality and efficient services. In order to achieve the goal of "Siemens Medical 2025 Strategy", by accelerating business expansion, exploring growth markets related to core businesses such as artificial intelligence, future diagnosis and treatment or technical support services, and completing the next phase of the goal in a more targeted way and method. , further consolidate our market leadership position. In China, Siemens Medical is committed to becoming a trusted partner for China's medical and health system and Chinese patients by meeting the most pressing medical needs. The company has launched a new China strategy for the next three years, and will be "customer-centric" in all aspects, targeting the differentiated needs of different customer groups, establishing a more focused and professional team, and providing an overall solution driven by digitalization. , meet the needs of Chinese customers. In 2022, Siemens Medical China officially released the localization strategy of "National Intelligence Innovation", aiming to deeply participate in the construction of a healthy China as a Chinese company. The upgraded strategy is divided into three dimensions: First, the company will gradually promote the localization of the entire product line, further enrich and improve the product lineage, meet the diversified needs of Chinese customers and patients, and help the local industrial chain transform and upgrade. Second, based on the demand of the Chinese market, the company further deepens its innovation and research and development. On the one hand, it accelerates the implementation of global leading technologies in China, benefiting doctors and patients as soon as possible, and on the other hand, it continues to explore local innovation. Third, the company continues to promote the upgrading of local business models, improve the large-scale application of medical equipment in all fields of the disease process, gradually improve the industrial ecology, and explore and practice multi-dimensional medical and industrial collaborative innovation model.
Siemens Healthineers AG
Siemens Medical is a world-renowned medical technology company. For 130 years, it has led the innovation of medical technology. The company continues to develop innovative products and services, including artificial intelligence-based applications and digital products that play an increasingly important role in the development of the new generation of medical technology, and further consolidates the fields of in vitro diagnosis, image-guided treatment, in vivo diagnosis and new cancer diagnosis and treatment. The basis of At the same time, Siemens Medical provides a wide range of services and solutions to help medical service providers improve their capabilities and provide patients with high-quality and efficient services. In order to achieve the goal of "Siemens Medical 2025 Strategy", by accelerating business expansion, exploring growth markets related to core businesses such as artificial intelligence, future diagnosis and treatment or technical support services, and completing the next phase of the goal in a more targeted way and method. , further consolidate our market leadership position. In China, Siemens Medical is committed to becoming a trusted partner for China's medical and health system and Chinese patients by meeting the most pressing medical needs. The company has launched a new China strategy for the next three years, and will be "customer-centric" in all aspects, targeting the differentiated needs of different customer groups, establishing a more focused and professional team, and providing an overall solution driven by digitalization. , meet the needs of Chinese customers. In 2022, Siemens Medical China officially released the localization strategy of "National Intelligence Innovation", aiming to deeply participate in the construction of a healthy China as a Chinese company. The upgraded strategy is divided into three dimensions: First, the company will gradually promote the localization of the entire product line, further enrich and improve the product lineage, meet the diversified needs of Chinese customers and patients, and help the local industrial chain transform and upgrade. Second, based on the demand of the Chinese market, the company further deepens its innovation and research and development. On the one hand, it accelerates the implementation of global leading technologies in China, benefiting doctors and patients as soon as possible, and on the other hand, it continues to explore local innovation. Third, the company continues to promote the upgrading of local business models, improve the large-scale application of medical equipment in all fields of the disease process, gradually improve the industrial ecology, and explore and practice multi-dimensional medical and industrial collaborative innovation model.
Mindray Medical International Limited
Shenzhen Mindray Biomedical Electronics Co., Ltd. is mainly engaged in the research and development, manufacturing, marketing and services of medical devices. It is always oriented towards customer needs and is committed to providing high-quality products and services to medical institutions around the world. The company integrates innovation, closely follows clinical needs, and supports medical institutions to provide high-quality medical services, thereby helping all over the world improve medical conditions and reduce medical costs. After years of development, the company has become a global advanced medical device and solution supplier. The company is headquartered in Shenzhen, China, with 40 overseas subsidiaries in more than 30 countries in North America, Europe, Asia, Africa, Latin America and other regions; it has 17 subsidiaries and more than 40 branches in China, forming a huge number of subsidiaries. a global R&D, marketing and service network. Since its establishment, the company has been deeply engaged in the medical device field, taking the path of equal importance to endogenous and extrinsic development, constantly expanding its product lines and regions, and has experienced the expansion from a single product to multiple product lines, and from the domestic market to the global market. At present, the company's products have covered three major areas: life information and support, in vitro diagnosis and medical imaging. It has a comprehensive product line in the same industry in China, and meets clinical practice with a safe, efficient and easy-to-use "one-stop" overall solution that meets clinical practice need. The company's products and solutions have been applied to more than 190 countries and regions around the world. In the domestic market, the company's products cover nearly 110,000 medical institutions in China and more than 99% of Grade A hospitals, including the nationally renowned Peking Union Medical College Hospital, the General Hospital of the People's Liberation Army of China, and Shanghai Ruijin Hospital. In the international market, as a long-term partner of global advanced medical institutions, such as Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Cleveland Medical Center, the company has won the United States, the United Kingdom, Germany, France, Italy. , Spain and other national medical institutions widely recognized.
Mindray Medical International Limited
Shenzhen Mindray Biomedical Electronics Co., Ltd. is mainly engaged in the research and development, manufacturing, marketing and services of medical devices. It is always oriented towards customer needs and is committed to providing high-quality products and services to medical institutions around the world. The company integrates innovation, closely follows clinical needs, and supports medical institutions to provide high-quality medical services, thereby helping all over the world improve medical conditions and reduce medical costs. After years of development, the company has become a global advanced medical device and solution supplier. The company is headquartered in Shenzhen, China, with 40 overseas subsidiaries in more than 30 countries in North America, Europe, Asia, Africa, Latin America and other regions; it has 17 subsidiaries and more than 40 branches in China, forming a huge number of subsidiaries. a global R&D, marketing and service network. Since its establishment, the company has been deeply engaged in the medical device field, taking the path of equal importance to endogenous and extrinsic development, constantly expanding its product lines and regions, and has experienced the expansion from a single product to multiple product lines, and from the domestic market to the global market. At present, the company's products have covered three major areas: life information and support, in vitro diagnosis and medical imaging. It has a comprehensive product line in the same industry in China, and meets clinical practice with a safe, efficient and easy-to-use "one-stop" overall solution that meets clinical practice need. The company's products and solutions have been applied to more than 190 countries and regions around the world. In the domestic market, the company's products cover nearly 110,000 medical institutions in China and more than 99% of Grade A hospitals, including the nationally renowned Peking Union Medical College Hospital, the General Hospital of the People's Liberation Army of China, and Shanghai Ruijin Hospital. In the international market, as a long-term partner of global advanced medical institutions, such as Mayo Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, Cleveland Medical Center, the company has won the United States, the United Kingdom, Germany, France, Italy. , Spain and other national medical institutions widely recognized.
Philips (China) Investment Co., Ltd.
Patients and medical care workers are the core of Philips' health care system. The services provided cross the boundaries of pure health care services and can provide users with a comprehensive and excellent health care service experience, which can greatly improve the patient's medical care effect and significantly reduce the Overall medical care costs. As a healthcare expert in heart disease, oncology, critical care and women, Philips is always committed to developing and providing healthcare solutions to provide users with value for money, ranging from disease prevention, radiation diagnosis to treatment, to Health management and monitoring, etc.
Philips (China) Investment Co., Ltd.
Patients and medical care workers are the core of Philips' health care system. The services provided cross the boundaries of pure health care services and can provide users with a comprehensive and excellent health care service experience, which can greatly improve the patient's medical care effect and significantly reduce the Overall medical care costs. As a healthcare expert in heart disease, oncology, critical care and women, Philips is always committed to developing and providing healthcare solutions to provide users with value for money, ranging from disease prevention, radiation diagnosis to treatment, to Health management and monitoring, etc.
Thermo Fisher Scientific (China) Co., Ltd.
Thermo Fisher Technology is a world leader in the field of scientific services, with annual sales exceeding US$30 billion. The company ’s mission is to help customers make the world healthier, cleaner and safer. Help customers accelerate research in the field of life sciences, solve complex problems and challenges encountered in the field of analysis, promote the development of medical diagnosis and treatment, and improve laboratory productivity. More than 80,000 Thermo Fisher employees around the world will provide customers with advanced innovative technologies, convenient procurement solutions and multi-faceted services through a series of industry-leading brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. Thermo Fisher Technology China In 1982, Thermo Fisher set up its first sales office in China, with its headquarters in Shanghai in China, and has established branches in Beijing, Guangzhou, Hong Kong, Chengdu, Shenyang, Xi'an, Nanjing, Wuhan, Jinan, Dongguan and other places. . The products mainly include analytical instruments, laboratory equipment, reagents, consumables and software, etc., provide comprehensive laboratory solutions to serve customers from all walks of life. In order to meet the needs of the Chinese market, the current eight factories are operated in Shanghai, Beijing, Suzhou and Guangzhou respectively. 6 application development centers and demonstration laboratories have been established nationwide to bring world-leading technologies and products to Chinese customers, and provide many services such as application development and training; China Innovation Centers located in Shanghai and Suzhou have more than 100 Professional researchers and engineers and more than 100 patents. The Innovation Center focuses on product research and development in vertical markets, combining the needs of the Chinese market and advanced technologies at home and abroad, and develops technologies and products suitable for Chinese users.
Thermo Fisher Scientific (China) Co., Ltd.
Thermo Fisher Technology is a world leader in the field of scientific services, with annual sales exceeding US$30 billion. The company ’s mission is to help customers make the world healthier, cleaner and safer. Help customers accelerate research in the field of life sciences, solve complex problems and challenges encountered in the field of analysis, promote the development of medical diagnosis and treatment, and improve laboratory productivity. More than 80,000 Thermo Fisher employees around the world will provide customers with advanced innovative technologies, convenient procurement solutions and multi-faceted services through a series of industry-leading brands Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. Thermo Fisher Technology China In 1982, Thermo Fisher set up its first sales office in China, with its headquarters in Shanghai in China, and has established branches in Beijing, Guangzhou, Hong Kong, Chengdu, Shenyang, Xi'an, Nanjing, Wuhan, Jinan, Dongguan and other places. . The products mainly include analytical instruments, laboratory equipment, reagents, consumables and software, etc., provide comprehensive laboratory solutions to serve customers from all walks of life. In order to meet the needs of the Chinese market, the current eight factories are operated in Shanghai, Beijing, Suzhou and Guangzhou respectively. 6 application development centers and demonstration laboratories have been established nationwide to bring world-leading technologies and products to Chinese customers, and provide many services such as application development and training; China Innovation Centers located in Shanghai and Suzhou have more than 100 Professional researchers and engineers and more than 100 patents. The Innovation Center focuses on product research and development in vertical markets, combining the needs of the Chinese market and advanced technologies at home and abroad, and develops technologies and products suitable for Chinese users.
Leica Microsystems (Shanghai) Co., Ltd.
The history of Leica microscopic imaging systems can be traced back to the 19th century. As a German optical manufacturing company, Leica microscopic imaging systems have a 160-year history of microscope production and have gradually developed into a manufacturer in the microscopic imaging system industry. Leica microscopic imaging system has always focused on product research and development and new technology applications. Leica Microscopy Systems has always maintained close ties with the scientific community and has continuously launched customized microscopy solutions for customers. Leica microscopy imaging system is mainly divided into three business departments: life sciences and research microscopy, industrial microscopy and surgical microscopy. Leica Microsystems has six R&D and manufacturing bases in five countries, and sales and service branches in more than 20 countries. Leica Microsystems is headquartered in Wetzlar, Germany .
Leica Microsystems (Shanghai) Co., Ltd.
The history of Leica microscopic imaging systems can be traced back to the 19th century. As a German optical manufacturing company, Leica microscopic imaging systems have a 160-year history of microscope production and have gradually developed into a manufacturer in the microscopic imaging system industry. Leica microscopic imaging system has always focused on product research and development and new technology applications. Leica Microscopy Systems has always maintained close ties with the scientific community and has continuously launched customized microscopy solutions for customers. Leica microscopy imaging system is mainly divided into three business departments: life sciences and research microscopy, industrial microscopy and surgical microscopy. Leica Microsystems has six R&D and manufacturing bases in five countries, and sales and service branches in more than 20 countries. Leica Microsystems is headquartered in Wetzlar, Germany .
Brook (Beijing) Technology Co., Ltd.
Brooke is committed to enabling scientists to make breakthrough discoveries and develop new applications to improve the quality of human life. Brooke’s high-performance scientific instrumentation and high-value analytical and diagnostic solutions enable scientists to explore life and materials at the molecular, cellular and micro levels. With close cooperation with customers, Brooke has achieved innovative breakthroughs and productivity improvements in life science molecular research, application and pharmaceutical applications, as well as microscopy, nanoanalysis and industrial applications, and has created many customer success stories. In recent years, Brooke has also become a provider of high-performance systems for cell biology, preclinical imaging, clinical imaging and proteomics research, clinical microbiology and molecular pathology research. Today, Brooke’s more than 7,500 employees worldwide are addressing this long-term challenge in more than 90 workplaces on various continents. Brooke insists on having a high reputation among customers for his extensive product and solutions and a broad foundation of installation systems. As one of the world's renowned analytical instrument companies, Brooke is committed to further fully meeting customer needs and continuously developing advanced technology and innovative solutions for today's analytical research work.
Brook (Beijing) Technology Co., Ltd.
Brooke is committed to enabling scientists to make breakthrough discoveries and develop new applications to improve the quality of human life. Brooke’s high-performance scientific instrumentation and high-value analytical and diagnostic solutions enable scientists to explore life and materials at the molecular, cellular and micro levels. With close cooperation with customers, Brooke has achieved innovative breakthroughs and productivity improvements in life science molecular research, application and pharmaceutical applications, as well as microscopy, nanoanalysis and industrial applications, and has created many customer success stories. In recent years, Brooke has also become a provider of high-performance systems for cell biology, preclinical imaging, clinical imaging and proteomics research, clinical microbiology and molecular pathology research. Today, Brooke’s more than 7,500 employees worldwide are addressing this long-term challenge in more than 90 workplaces on various continents. Brooke insists on having a high reputation among customers for his extensive product and solutions and a broad foundation of installation systems. As one of the world's renowned analytical instrument companies, Brooke is committed to further fully meeting customer needs and continuously developing advanced technology and innovative solutions for today's analytical research work.
